Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel

Gynecologic Oncology

Volumn 89, Issue 3, 2003, Pages 494-498

  Hirsh Yechezkel, G ^a   Chetrit, A ^a   Lubin, F ^a   Friedman, E ^b   Peretz, T ^c   Gershoni, R ^d   Rizel, S ^e   Struewing, J P ^f   Modan, B ^g  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e RABIN MEDICAL CENTER   (Israel)

^f NATIONAL CANCER INSTITUTE   (United States)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

BRCA carriers; Israeli population; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ISRAEL; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUTATIONAL ANALYSIS; OVARY CARCINOMA; OVARY TUMOR; PERITONEUM CANCER; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

EID: 0037836054     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00152-5     Document Type: Article

References (17)

1. Simard J., Tonin P., Durocher F., Morgan K., Rommens J., Gingras S., Samson C., Leblanc J.-F., Bélanger C., Dion F., Liu Q., Skolnick M., Goldgar D., Shattuck-Eidens D., Labrie F., Narod S.A. Common origin of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet. 8:1994;392-398.
2. Struewing J.P., Brody L.C., Erdos M.R., Kase R.G., Giambarresi T.R., Smith S.A., Collins F.S. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including one family with male breast cancer. Am J Hum Genet. 57:1995;1-7.
3. Tonin P., Weber B., Offit K., Couch F., Rebbeck T.R., Neuhausen S., Godwin A.K., Daly M., Wagner-Costalos J., Berman D., Grana G., Fox E., Kane M.F., Kolodner R.D., Krainer M., Haber D.A., Struewing J.P., Warner E., Rosen B., Lerman C., Peshkin B., Norton L., Serova O., Foulkes W.D., Lynch H.T., Lenoir G.M., Narod S.A., Garber J.E. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 2:1996;1179-1183.
4. Muto M.G., Cramer D.W., Tangir J., Berkowitz R., Mok S. Frequency of the 185delAG mutation among Jewish women with ovarian cancer and matched population control. Cancer Res. 56:1996;1250-1252.
5. Modan B., Gak E., Bar-Sade Bruchim R., Hirsh-Yechezkel G., Theodor L., Lubin F., Ben-Baruch G., Beller U., Fishman A., Dgani R., Menczer J., Papa M., Friedman E. High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. JAMA. 276:1996;1823-1825.
6. Abeliovich D., Kaduri L., Lerer I., Weinberg N., Amir G., Sagi M., Zlotogora J., Heching N., Peretz T. The founder mutations 185delAG and 5382insC in BRCA1 and 6147delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet. 60:1997;505-514.
7. Levy-Lahad E., Catane R., Eisenberg S., Kaufman B., Homreich G., Lishinsky E., Shohat M., Weber B.L., Beller U., Lahad A., Halle D. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families . Am J Hum Genet. 60:1997;1059-1067.
8. Beller U., Halle D., Catane R., Kaufman B., Hornreich G., Levy-Lahad E. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Lewish ovarian cancer patients, regardless of family history. Gynecol Oncol. 67:1997;123-126.
9. Modan B., Hartge P., Hirsh-Yechezkel G., Chetrit A., Lubin F., Beller U., Ben-Baruch G., Fishman A., Menczer J., Ebbers S.M., Tucker M.A., Wacholder S., Struewing J.P., Friedman E., Piura B. Parity, oral contraceptive, and the risk of ovarian cancer among carriers and non-carriers of a BRCA1 or BRCA2 mutation. N Engl J Med. 345:2001;235-240.
10. Struewing J.P., Coriaty Z.M., Ron E., Livoff A., Konichezky M., Cohen P., Resnick M.B., Lifzchiz-Mercerl B., Lew S., Iscovich J. Founder BRCA1/2 mutations among male patients with breast cancer in Israel. (Letter). Am J Hum Genet. 65:1999;1800-1802.
11. Struewing J.P., Hartge P., Wacholder S., Baker S.M., Berlin M., McAdams M., Timmerman M.M., Brody L.C., Tucker M.A. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 336:1997;1401-1408.
12. Moslehi R., Chu W., Karlan B., Fishman D., Risch H., Fields A., Smotkin D., Ben-David Y., Rosenblatt J., Russo D., Schwartz P., Tung N., Warner E., Rosen B., Friedman J., Brunet J.S., Narod S.A. BRCA1 and BRCA2 mutation Analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet. 66:2000;1259-1272.
13. Tobias D.H., Eng C., McCurdy L.D., Kalir T., Mandelli J., Dottino P.R., Cohen C.J. Founder BRCA1 and 2 mutations among consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol. 78:2000;148-151.
14. Lu K.H., Cramer D.W., Muto M.G., Li E.Y., Niloff J., Mok S.C. A population-based study of BRCA1 and BRCA2 mutation in Jewish women with epithelial ovarian cancer. Obstet Gynecol. 93:1999;34-37.
15. Schubert E.L., Mefford H.C., Dann J.L., Argonza R.H., Hull J., King M.C. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genet Testing. 1:1997;41-46.
16. Struewing J.P., Tarone R.E., Brody L.C., Li F.P., Boice J.D. Jr. BRCA1 mutations in young women with breast cancer. Lancet. 347:1996;1493.
17. Krainer M., Silva-Arrieta S., FitzGerald M.G., Shimada A., Ishioka C., Kanamaru R., MacDonald D.J., Unsal H., Finkelstein D.M., Bowcock A., Isselbacher K.J., Haber D.A. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med. 336:1997;1448-1449.